We spoke to Dr Vias Markides (Royal Brompton & Harefield NHS Foundation Trust, London, UK) at the 2019 Heart Rhythm Congress (HRC) in Birmingham, UK, for his thoughts on the customisation of atrial fibrillation treatment strategies and whether it is yet achievable in practice.
Speaker’s Disclosures: Vias Markides has a consultancy agreement with Biosense Webster.
1. Customisation of atrial fibrillation strategy – is this truly achievable yet? (0:09)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the Heart Rhythm Congress (HRC) 2019 in Birmingham, UK, October 2019 in partnership with Arrhythmia Alliance.
Share this Video
Related Videos In Atrial Fibrillation
Manesh Patel, ACC 2022: PACIFIC-AF: Multicenter, Randomized, Active Comparator-controlled, Double-blind, Dose-finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian With Apixaban in Patients With Atrial Fibrillation
PACIFIC-AF is a multicenter, randomized, active comparator-controlled, double-blind, double-dummy, parallel group, dose-finding phase 2 study comparing the safety of the oral FXIa inhibitor asundexian with apixaban in patients with atrial fibrillation. It was a pleasure to speak with Prof. Manesh Patel (Duke University, Durham, NC) who gives an overview on asendexian; its future in the […]
Tanja Potpara, EHRA 2022: NOAC patient journey: i.e. bridging, ACS/PCI, renal dysfunction and comedication
Dr Tanja Potpara (Belgrade University School of Medicine, Belgrade, Serbia) kindly discussed with us her presentation on the journey of patients on novel oral anticoagulants (NOACs), which was presented during a session on atrial fibrillation clinical cases with focus on rhythm control and anticoagulation at this years EHRA. ‘NOAC patient journey: i.e. bridging, ACS/PCI, renal […]
Luigi Di Biase, AFS 2022: Peri and Post Procedural Anticoagulation with LAA Closure Devices
The advantages and challenges of peri and post procedural anticoagulation with LAA closure devices were discussed by Prof. Luigi Di Biase in a short interview with touchCARDIO, at the annual AF Symposium 2022. The abstract entitled ‘Peri and Post Procedural Anticoagulation with LAA Closure Devices – An Evolving Story’ was presented at the annual AF […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!